Insider Transactions in Q1 2024 at Liquidia Corp (LQDA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,657
-2.06%
|
$69,855
$15.66 P/Share
|
|
Mar 18
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
260
+0.23%
|
-
|
|
Mar 18
2024
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,583
-3.31%
|
$428,745
$15.82 P/Share
|
|
Mar 18
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,530
-1.7%
|
$112,950
$15.82 P/Share
|
|
Mar 18
2024
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
12,166
-1.85%
|
$182,490
$15.82 P/Share
|
|
Mar 18
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,108
-3.83%
|
$91,620
$15.82 P/Share
|
|
Mar 18
2024
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
8,653
-0.87%
|
$129,795
$15.82 P/Share
|
|
Mar 15
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+12.14%
|
-
|
|
Mar 15
2024
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.7%
|
-
|
|
Mar 15
2024
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.47%
|
-
|
|
Feb 29
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
455
-0.46%
|
$6,370
$14.17 P/Share
|
|
Feb 29
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+1.57%
|
-
|
|
Feb 29
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
546
-0.34%
|
$7,644
$14.17 P/Share
|
|
Feb 29
2024
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.16%
|
-
|
|
Jan 15
2024
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.29%
|
-
|
|
Jan 11
2024
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
110,135
+18.27%
|
-
|
|
Jan 11
2024
|
Roger Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
221,338
+20.43%
|
-
|
|
Jan 11
2024
|
Jason Adair Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,588
+29.52%
|
-
|
|
Jan 11
2024
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
93,250
+25.24%
|
-
|
|
Jan 11
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
49,723
-24.12%
|
-
|
|
Jan 11
2024
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,492
+20.39%
|
-
|